August 24, 2016 10:34 AM EDT
News Briefing

Pro­to­cols: Cell Med­ica strikes a TCR re­search deal with Uni­ver­si­ty Col­lege Lon­don; UK of­fers ear­ly ac­cess to Ab­b­Vie's vene­to­clax

John Carroll

Editor & Founder

A few months af­ter strik­ing a CAR-T pact with Bay­lor, Cell Med­ica has struck a deal to work with Uni­ver­si­ty Col­lege Lon­don on new …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ap­plied Ther­a­peu­tic­s' rare dis­ease drug gets a CRL

FDA is look­ing in­to hema­tol­ogy risks af­ter pa­tients take Blue­bird's Skysona gene ther­a­py

PTC re­ports Phase 2 ALS fail, sells pri­or­i­ty re­view vouch­er for $150M

No­var­tis to cut 139 jobs in NJ as part of com­mer­cial re­fo­cus

Nor­bert Bischof­berg­er's time as Kro­nos CEO ends as biotech seeks new life

Bris­tol My­ers sues the fed­er­al gov­ern­ment over 340B, fol­low­ing oth­er drug­mak­ers

A service from the Financial Times